Evaluating the impact of the human papillomavirus vaccine in Latin America and the Caribbean
978-92-75-12739-1 (PDF)978-92-75-12740-7 (print version)
MetadataShow full item record
In women, cervical cancer is the leading cause of cancer death in six countries and the second leading cause of death in 14 others. Each year, more than 70,000 new cervical cancer cases are diagnosed, and more than 35,000 women in the Region will die due to this disease. The Human Papilloma Virus (HPV) 16 and HPV-18 are responsible for around 70% of these cancers. Vaccination against HPV - in addition to adopting new approaches to screening and improving the quality of cancer treatment, palliative care, and cancer registration - is a safe and effective form of protection against high-risk HPV types. As of December 2022, 47 countries and territories of the Americas ha incorporated HPV vaccines into their national immunization programs prioritizing girls between 9 and 14 years of age, following PAHO's TAG recommendations. As a primary tool for the fight against cervical cancer, achieving high vaccination coverage and monitoring and evaluating the performance of HPV vaccination programs and their impact on HPV-related morbidity and mortality must be a priority. As such, this document offers a broad overview of design used to assess the impact of HPV vaccination to help sustain country investments and support the goal of eliminating cervical cancer. The primary audience for this document includes managers and professionals of national immunization programs, epidemiologists from Ministries of Health or institutions involved in vaccination impact studies, professionals from HPV reference laboratories and epidemiologists working on cervical cancer prevention. In addition, this document could be useful for epidemiologists working on other HPV-related diseases, researchers in academic universities or other institutions, pathologists who interpret cervical screening Pap tests (cytology), non-governmental organizations, public health leaders and officials and medical professionals.
Pan American Health Organization. Evaluating the impact of the human papillomavirus vaccine in Latin America and the Caribbean. Washington, D.C.: PAHO; 2023. Available from: https://doi.org/10.37774/9789275127391.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Systematic literature review of pri- mary and secondary cervical cancer prevention programs in South America Gomes, Maria Luziene de Sousa; Moura, Nádya dos Santos; Magalhães, Letícia de Carvalho; Silva, Roger Rodrigues da; Silva, Bárbara Gomes Santos; Rodrigues, Ivana Rios; Sales, Luiz Belino Ferreira; Oriá, Mônica Oliveira Batista (2023)[ABSTRACT]. Objective. To identify the 2022 recommendations made by ministries of health in the 13 countries and areas of South America for human papillomavirus (HPV) vaccination and cervical cancer screening. Methods. A ...
HPV Vaccination: Toward the Elimination of Cervical Cancer in the Caribbean Countries. Virtual Meeting Report, 22–23 and 29–30 October 2020 Pan American Health Organization; Family, Health Promotion and Life Course (FPL) (PAHOUnited StatesWashington, D.C., 2021-09-14)In October 2020, 30 participants and 14 panelists from the ministries of health from the Caribbean subregion, the Pan American Health Organization (PAHO), the World Health Organization, and various other institutions took ...
De la Hoz Restrepo, Fernando; Alvis Guzman, Nelson; De la Hoz Gomez, Alejandro; Ruiz, Cuauhtémoc (2017-12)[ABSTRACT]. Objectives. Three highly effective vaccines are available to prevent human papillomavirus (HPV) infection, and they have been introduced in many countries around the world. This article describes advances and ...